The article below may contain offensive and/or incorrect content.
MW189, a small molecule drug candidate, blocks abnormal inflammation in the brain which contributes to injury and disease induced neurological impairments.Article Correctness Is Author's Responsibility: First in-human study of drug targeting brain inflammation supports further development
MW189, a small molecule drug candidate, blocks abnormal inflammation in the brain which contributes to injury and disease induced neurological impairments.
